| Tecan And ForteBio Automate Label-Free Assays For bioprocess And Drug Discovery Applications |
|
|
|
![]() |
![]() |
| Tuesday, 09 March 2010 05:45 | |||
|
Tecan has designed a Freedom EVO deck extension plate to mount the Octet 384 instrument securely on the right hand side of the workstation. A robotic manipulator arm performs automated transport and handling of plates and sensor trays, and an 8-channel liquid handling arm with fixed or disposable tips is used to prepare assay plates. A MultiChannel Arm™ (MCA), with a 384- or 96-channel pipetting head, can also be specified for higher throughput applications. Kevin Moore, Tecan’s Director of Market and Application Management for BioPharma, said: “We are very pleased to be working with ForteBio to bring an automation solution to customers in this fast growing area of label-free detection.” ForteBio’s Octet platform enables reliable high throughput measurements for protein-protein, protein-peptide, protein-small molecule and fragment screening assays, using the innovative Dip and Read™ biosensors. The Octet systems use proprietary biolayer interferometry (BLI) to provide real-time, label-free analysis of biomolecular interactions. “We are delighted to partner with Tecan, enabling Octet customers to process batches of assay plates and automate sample handling for Dip and Read biosensor assays, allowing greater throughput and increased efficiency,” concluded Christopher Silva, ForteBio’s Vice President of Marketing. For more information about Tecan, please contact: About Tecan Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of automation solutions for laboratories in the life sciences sector. With its subsidiary REMP (www.remp.com), Tecan is the market leader in automated laboratory storage and logistics systems. Its clients include pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2008, Tecan generated sales of CHF 396 million (USD 366.7 million; EUR 250.7 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).
Source: Tecan
|
| Add comment | Add to my library | Forward this article |